Colin Ng & Partners LLP acts as Singapore counsel to the Link Healthcare Group on its acquisition by Clinigen Plc.

Colin Ng & Partners LLP acts as Singapore counsel to the Link Healthcare Group on its acquisition by Clinigen Plc.

Colin Ng & Partners LLP (“CNP”) acted as Singapore counsel for Link Healthcare (“Link”), a specialist pharmaceutical and medical technology business focussed on the Asian, African and Australasian (‘AAA’) regions, on the sale of Link to Clinigen Group plc (‘Clinigen”), the specialty global pharmaceutical company listed inthe UK, for an initial consideration of £44.5 million and a maximum of approximately £100 million based on achievement of milestones.

 

Clinigen agreed to acquire Link in late September 2015 and the acquisition was completed on 30 October 2015. CNP Partners Bill Jamieson and Amit Dhume advised Link.

 

For more information, please contact:

            Gillian Chan

Corporate Communications Manager

Colin Ng & Partners LLP

DID: 6349 8756

Fax: 6323 8282

E-mail: [email protected]